Showing posts with label health care financing. Show all posts
Showing posts with label health care financing. Show all posts

Wednesday, March 11, 2026

Current Business Practices and Financing the Health Care Industry In the US - Don't Work

 




My last post discussed current and historical business practices to ration medical care and increase profits by reducing reimbursement to hospitals and physicians while decreasing benefits to patients.  The net result of those practices is shifting the cost of care to patients or in the extreme case just not paying the bills at all.  The current situation at Hennepin County Medical Center was the case in point. 

This morning an article came out in the Star Tribune  HCMC is too big to fail, but Hennepin County leaders say it’s now on life support (1).  That well-worn description of being too big to fail misses the point that many large county hospitals have failed.  It did not matter how many services they provided or the fact they were training physicians.  In one famous case all of the physician trainees were informed the hospital was closing and they needed to find a new training program. 

The most famous case was Hahnemann Medical Center in Philadelphia 2019.  In that case 570 trainee across 35 separate programs.  Hahnemann had been a safety net hospital for low-income populations for over 170 years.  The permanent closure of Hahnemann resulted in 20% increase emergency room volumes and an 80% increase in wait times. An additional 12-14 Pennsylvania hospitals are at risk of closing by 2031 largely due to reductions in Medicaid funding.

The Hahnemann closure was one of the first examples of what can happen to healthcare assets under private equity management.  In the case of Hahnemann, there was a debt financed purchase of the hospital. The real estate assets were spun off into private management while the hospital was left to pay off a high interest loan and went bankrupt 18 months after the acquisition.  There was controversy about the 570 residency slots and 6 local healthcare networks bid $55M – but courts eventually ruled that they were not assets.  The properties were eventually broken up and sold to recoup the cost of the bankruptcy.  The state of Pennsylvania passed laws to prevent hedge funds or private equity from interfering with healthcare businesses that are in the public interest and they require a 6 month notice with a closure plan for any hospital in the state.

Almost on cue – the New England Journal of Medicine (NEJM) came out with three commentaries (4-6)  on what can only be described as the predatory financing of healthcare.  For the record – I consider rationed healthcare and cost shifting and all the mechanisms associated with that - predatory financing.  Healthcare is about the only field I know where you can do the work, business managers can decide not to pay you, and they are backed up by some government regulation. It is not like the work is elective or some kind of scam.  In all my years of acute care psychiatry – I was not pulling people in off the street.  I was generally trying to solve severe problems that many other people had decided required hospital care and passed on to me.  Despite that consensus – some business manager could decide against reimbursement or decide the patient should pay the bill even if they thought they were covered.

The first paper looks at the issue of health care equity and the effects of private equity (PE).  In an ideal world, private equity companies are supposed to raise capital to acquire companies, take control of them, improve their efficiency and then sell them in a fairly short period of time.  The general idea is that PE has substantially higher returns on investment than typical stock market investments.  As the PE industry has grown, the premium return for investors has become more debatable.

The first paper in the NEJM Perspective looks at the impact of PE on healthcare financing. The use the CDC definition of health equity:

“Health equity is the state in which everyone has a fair and just opportunity to attain their highest level of health. Achieving this requires focused and ongoing societal efforts to address historical and contemporary injustices; overcome economic, social, and other obstacles to health and healthcare; and eliminate preventable health disparities.” CDC

As noted in the previous post the safety-net hospital concept is there to address income and healthcare insurance inequity.  The Emergency Medical Treatment & Labor Act (EMTALA) law is another.  EMTALA is commonly recognized as a rule that no emergency department can turn a person away who requires that level of care based on ability to pay. 

The authors in this piece describe accumulating evidence that PE has reduced access to care for many vulnerable populations including rural, elderly, low-income, and racial and ethnic groups.  Several policy factors and failures have led to an expansion of PE investment. There is a concern that there is limited oversight of these companies compared with publicly traded companies.  The authors provide several examples of tactics used by PE firms that have led to the failure of the medical entity, reduced or no access for patients, and greater profits for the investors.

The first tactic is a sale-leaseback transaction. The medical facilities acquired are sold to an entity affiliated with the firm and leased back to the hospital or clinic at inflated rates.  During a dividend recapitalization the PE takes on additional debt to pay investors rather than investing in the medical business. They give an example of a system where these measures led to tripled debt while senior managers got large bonuses.

Quality of care has been a marginal issue since managed care took over medicine in the mid-1990s.  In the above example, quality of care declined to the point it was ranked among the worst in the state and it was eventually closed leaving residents no access to acute care. They cite increased deaths in emergency departments and after surgeries. The same company had a venture in another state that failed as well. The formula involved cost savings at the expense of employees (lay-offs, reduced FTEs, reducing physicians in favor of extenders, and cutting low margin services).  On the administrative side upcoding, surprise bills, and higher charges are used as well as selecting younger and healthier patients. 

They suggest several fixes to the various PE problems that involve targeting management and accounting practices that can result in profits for investors, but closed hospitals, produced bad debt, and resulted in no access to emergency care for the patients involved.   Some of those suggestions include personal liability for some of the company officers and clawback provisions for profits made by some of these exploitative techniques.  There were no suggestions about adequate reimbursement for hospitals in the first place.

The second paper (3) discusses a political change at the Centers for Medicare and Medicaid Services (CMS).  Since the Trump administration is focused on denying that a lack of equity exists in the country they have changed the focus to efficiency. Efficiency as in free-market solutions is a long time Republican slogan that lacks any evidence that it is useful in healthcare.  The most significant piece of evidence that free markets do not work is the existence of Medicare and Medicaid and the remarkable number of people and services that they cover. Without those programs – none of that healthcare would be delivered and there would be considerably more morbidity and mortality.

The program titles have changed from States Advancing All-Payer Health Equity Approaches and Development to Achieving Healthcare Efficiency through Accountable Design (AHEAD).  It replaces equity plans with accountability plans including “chronic disease prevention, choice, and competition.”  On the choice side of the equation increased telehealth, and decreasing qualifications for networks and providers.  This seems to be a straightforward approach to decreasing quality to produce a cheaper product. The authors do not state that explicitly but say there is limited evidence it would work. 

The most likely outcome of AHEAD is that it will decrease investment in safety net facilities.  Combined with Medicaid funding reductions the impact on safety net hospitals will likely be significant. 

The final paper was about medical credit cards.  Before reading this paper – I could not think of a worse idea.  The threat of medical bankruptcy drives the for-profit medical industry in the US.  Most medical bankruptcies occur in the US.  That combined with medical charges and the way they are billed is the primary reason Americans are highly motivated to have health care insurance. At the time of this post the Annual percentage Rate (APR) of credit cards in the US is between 20 and 25% depending on credit rating and other factors.  About 8-9% of the population has medical debt. Three million owe over $10,000.  Since credit cards calculate daily interest – it could take 20 years to pay off this debt by paying the minimum amounts.

One in every 4 people with medical debt is using a credit cared to pay it off.  There can be incentives on both sides of the equation.  From the billing side – it is paid of on a timely basis.  From the consumer side – there can be delayed interest arrangements if the debt of paid off in a specified interval.  That has led to most medical credit card sign up occurring in medical offices.  Compared with the APR rates for typical consumer cards medical cards may be as high as 40% - people with the lowest credit ratings incurring the highest rates. 

Medical credit cards are complicated by the fact that insurance companies may not be paying the same rates for the same services that are being charged to cards due to negotiated deals.  The person paying cash pays the higher amount.  In some cases, people may qualify for medical assistance programs but they are not informed about this option.  The medical providers offering the cards may get a rebate in terms of lower transaction fees.

The overall conclusion of this final paper is that medical organizations should not actively market medical credit cards to patients. They suggest that the existing federal laws be expanded to provide transparency about terms of medical credit cards and offer more payment options. In my experience, no patient should be charged more than an insurance company for the same service just because they are paying cash and are not part of a negotiated fee schedule. Most of the health care organizations in Minnesota offer monthly payments with specified minimums – but the interest calculations may not be clear.

In summary what can be learned from the recent financial problems with Hennepin County Medical Center and these perspective in the NEJM.  First, the public and private financing of the US healthcare system is getting progressively more precarious.  There are more safety net and rural hospital failures, less quality care, and more expansion of private equity investment.  Second, despite the emphasis on access and cost both of those measures are diminished significantly by the current financing structures. Despite the current administration’s emphasis on efficiency over equity there is no way efficiency can be maintained when there are large shifts in emergency department utilization and admissions due to the elimination of safety net hospitals.  Third – there are an endless number of ways the system can be gamed to make money or avoid regulation. Much of that gaming is in the form of rationing and cost shifting but there are also accounting maneuvers to make it seem like the required amount of financing dollars is going to medical care.  How is that possible in a system that has seen a 3,000% increase in administrators compared with a 100% increase in physicians over the past 50 years?

The only rational solution at this point is to eliminate the healthcare companies and go to a single payer system.  Single payer Medicare for all is an idea that is more frequently floated these days.  Medicare traditionally has vey low administrative costs but it admittedly is less intensive than managed care organizations. In the previous post I cite the Swiss system as saving a trillion dollars per year if applied to the US system.  I have seen experts debate how healthcare financing in other countries might affect the US.  I think the only way to find out is to bring experts from Switzerland to the US and suggest how to make that transition.

It is apparent that nether political party in the US is capable of the task. 

     

George Dawson, MD, DFAPA

 

References:

1:  Roper E.  HCMC is too big to fail, but Hennepin County leaders say it’s now on life support.  Minneapolis Star Tribune. March 8, 2026.

2: Rosenbaum L. Losing Hahnemann - Real-Life Lessons in "Value-Based" Medicine. N Engl J Med. 2019 Sep 26;381(13):1193-1195. doi: 10.1056/NEJMp1911307. Epub 2019 Aug 28. PMID: 31461591.

3:  Pomorski C.  The Death of Hahnemann Hospital. New Yorker.  June 7, 2021, Vol. 97 Issue 15, p30-37.

Excellent look at the chaos and fragmentation of health care that happens when a large safety net hospital closes and how it happens during a private equity leveraged deal.

4:  Yearby R, Alsan M. Private Equity's Transformation of American Medicine - Implications for Health Equity. N Engl J Med. 2026 Mar 5;394(10):937-940. doi: 10.1056/NEJMp2415615. Epub 2026 Feb 28. PMID: 41770029.

5:  Figueroa JF, Meara E. From Equity to Efficiency - Navigating Changes to the AHEAD Model. N Engl J Med. 2026 Mar 5;394(10):940-943. doi: 10.1056/NEJMp2514355. Epub 2026 Feb 28. PMID: 41770017.

6:  Alvarez A, Sloan CE, Ubel PA. Debt by Design - Navigating the Hazards of Medical Credit Cards. N Engl J Med. 2026 Mar 5;394(10):943-945. doi: 10.1056/NEJMp2514612. Epub 2026 Feb 28. PMID: 41770001.

Monday, March 24, 2014

The Problem With Making Medical Information More Like Financial Information

I have been an interested reader of financial information for the the past 40 years.  My uncle was an avid stock market investor when I was a kid and he got me interested in reading the Value Line investment  survey.  I still read it and base some of my decisions on it.  Over the years I have had some degree of success in investing, but it hasn't all been good.  One of my greatest successes was a defensive maneuver that resulted in me not losing anything during the stock market crash of 2008.  I have been a subscriber at one time or another to most of the significant investment magazines and newspapers in the United States.

It has been interesting to observe what has happened to what has come to be known as the financial services industry over my investing career because it has implications for the increasing business control over medicine.  I have already alluded to many on these implications on this blog including treating knowledge workers like production workers and creating an unhealthy work environment that results in a lack of empathy for the patients being treated.  But there are even larger implications.  Financial services industry friendly legislation has probably been the single largest contributor to the idea that the privacy of individuals is relative to the advantages gained by establishing credit reporting.  Credit reporting agencies were born out of the idea that data could be collected under a Social Security Number and released to any financial institution without the consent of the person behind that SSN.  That single idea violated a previous promise by Congress that SSNs would not be used as any type of national identifier and was single handedly responsible for creating a multi-billion dollar industry that basically buys and sells credit information and the identity theft industry - both the criminal side and the services to protect people from the criminals.  It is much harder to be an identity thief in a world that does not have credit information centralized on a SSN.

The driving force behind businesses everywhere is to create leverage that results in people needing to buy a product or service and make it so they can't get it anywhere else.  We hear a lot about competition and its importance in capitalism, but there is plenty of evidence that capitalism is not only lacking but that measures are often in place to severely restrict it.    It results in an industry that is set up to optimize gain from consumers while keeping them all at risk.  As an example, one of the "low risk" strategies for investing with some of these companies is to investment in index funds.  As retirement nears, the recommendation can be to put funds into an annuity or with an advisor who can determine withdrawal rates, reallocation, and future investment decisions.  In many cases the retiree is charged up to 1% for that service on top of whatever service charges and transaction fees are associated with the funds that are invested in.  There is always the disclaimer that there is no guarantee of income from the account and this is compounded by the fact that interest on cash and money market funds is at an all time low.  Very few investors can fund their retirement by interest on so-called safe investments and in the last decade we have witnessed the first losses on money market funds.  All things considered, regulation at all levels seems like it is clearly set up to favor the financial services industry.  They have a license to warn you that you can lose money even though you may be paying them to protect it - and that's OK.  In some extreme examples, investment banks have recommended purchases to customer that they were actively betting against.

I don't know how many people can see the trend, but it is pretty obvious to me.  As medical information gets more like financial information - it moves farther away from any reality basis and it becomes a vehicle for manipulation.  The whole point of collecting data from a medical and scientific standpoint is to look at underlying meaning specifically implications for health care.  The best example is lab data.  If I look at a patient's CBC with differential count and chemistry profile,  I have about 40 data points, any one of which could have significant health implications for the care of that individual.  If I look at various quality markers and screening scores that are being collected for business purposes that data varies from questionable to clearly invalid and yet physicians are being held "accountable" for what is essentially business quality data.  In other words, data that has no scientific basis and can be manipulated for a specific result.  The usual intent is to maximize business profits and make it seem like the business is much more critical to the provision of health care than the health professionals it hires.  As absurd as that last sentence looks, it is without a doubt one of the goals of most health care businesses.

Business information collected and manipulated for the sake of furthering business interests in the health care industry is no more valid than  what happens in the financial services industry.  Both types of information have evolved to place the consumer at risk all of the time and give them no clear reason for a making a decision in their own interest.  And in both cases, consumers have no choice but to participate.  We have a government mandated retirement industry that provides a windfall to financial services.  We now have a government mandated health care industry that is set to provide a windfall the large health care and pharmaceutical companies.  In both cases it is underwritten by the American consumer who is placed at financial risk all of the time in an economy of stagnant wages and significant unemployment.

George Dawson, MD, DFAPA